Skip to content

The effect of patient education on diabetes control

The effect of a learning style based education on metabolic control, quality of life and empowerment of patients with type 2 diabetes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT201302222621N12
Enrollment
216
Registered
2013-06-06
Start date
2013-01-27
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes. Insulin-dependent diabetes mellitus, Non-insulin-dependent diabetes mellitus

Interventions

Intervention 1: Multimoda education Target group: intervention 1 group Numbers of participants in each calass: 12 This education program is a integration of styles includes: visual, aural, read-write,
Multimoda education Target group: intervention 1 group Numbers of participants in each calass: 12 This education program is a integration of styles includes: visual, aural, read-write, and kinesthe
Learning style based education Target group: intervention 2 group Numbers of participants in each calass: 12 Patients in this group participate in education class based on their preferred learning
Routine education program Target group: control Numbers of participants in each class: 12 The patients in this group participate in the lecturing routine class which is conducted in the clinic. Du

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: type 2 diabetes; tending to participate in research; ability to understand the content based on the researcher's judgment; not participating in similar educational classes in the past 6 months and reading and writing literacy. Exclusion criteria: unwillingness to continue participation in the study and stressful condition or surgery during the study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Fasting Blood Sugar. Timepoint: Baseline and 3 months after intervention. Method of measurement: mg/dl.;Haemoglobin A1c. Timepoint: Baseline and 3 months after intervention. Method of measurement: percent.;Tryglyceride. Timepoint: Baseline and 3 months after intervention. Method of measurement: mg/dl.;Cholesterol. Timepoint: Baseline and 3 months after intervention. Method of measurement: mg/dl.;Low Density Lipoprotein. Timepoint: Baseline and 3 months after intervention. Method of measurement: mg/dl.;High Density Lipoprotein. Timepoint: Baseline and 3 months after intervention. Method of measurement: mg/dl.;Empowerment. Timepoint: Baseline and 3 months after intervention. Method of measurement: michigan diabetes empowerment questionnaire.;Quality of life. Timepoint: Baseline and 3 months after intervention. Method of measurement: Quality of Life Instrument for Indian Diabetes Patients (QOLID).;Body Mass Index. Timepoint: Baseline and 3 months after intervention. Method of measurement: (height)2 /(weight).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Marzieh Moattari

Shiraz University of Medical Scienses

moattarm@sums.ac.ir+98 71 1647 4254

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026